Gregory W. Roloff, MD

Articles by Gregory W. Roloff, MD

$Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.$

Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL

ByGregory W. Roloff, MD

June 25th 2023

Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.

Latest Updated Articles

$Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.$
Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL
Published: June 25th 2023 | Updated:

Gregory W. Roloff, MD

Articles by Gregory W. Roloff, MD

Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Durvalumab Plus FLOT in Resectable Gastric/GEJ Cancers

Non-Viral Gene Therapy Displays Feasibility in EGFR-Mutated NSCLC

Novel Bispecific ADC Earns FDA Fast Track Status in Urothelial Cancer

Temferon Yields Preliminary Survival in Newly Diagnosed Glioblastoma Trial

Immune Priming Strategies Numerically Improve PFS in Ovarian Cancer